Search
Now showing items 1-1 of 1
PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection
(2023-01-24)
Background The intensity of inflammation during COVID-19 is related to adverse outcomes. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is involved in low-density lipoprotein receptor homeostasis, with potential ...